Your fact-checks will appear here
FDA's role in regulating supplements, including coordination with FTC on misleading claims
Human studies identify three dietary levers that most reliably stimulate endogenous GLP‑1 secretion: protein (particularly intact or rapidly digested proteins), long‑chain unsaturated fatty acids (e.g...
Clinical and preclinical studies show exogenous beta‑hydroxybutyrate (BHB) can augment fat loss and help preserve lean mass while it is being taken (notably in short‑ to medium‑term trials), but there...
Collagen peptides do not appear to cause harmful, isolated “insulin spikes” in the sense of provoking pathological hyperinsulinemia; instead, preclinical and limited clinical data show collagen peptid...
Clinical and mechanistic studies show plausible pathways by which berberine and certain probiotics could raise GLP‑1 secretion, but controlled human trials demonstrating a reproducible, physiologicall...